Abstract
Journal of Neuroinflammation is an Open Access, online journal published by BioMed Central. Open Access publishing provides instant and universal availability of published work to any potential reader, worldwide, completely free of subscriptions, passwords, and charges. Further, authors retain copyright for their work, facilitating its dissemination. Open Access publishing is made possible by article-processing charges assessed "on the front end" to authors, their institutions, or their funding agencies. Beginning November 1, 2004, the Journal of Neuroinflammation will introduce article-processing charges of around US$525 for accepted articles. This charge will be waived for authors from institutions that are BioMed Central members, and in additional cases for reasons of genuine financial hardship. These article-processing charges pay for an electronic submission process that facilitates efficient and thorough peer review, for publication costs involved in providing the article freely and universally accessible in various formats online, and for the processes required for the article's inclusion in PubMed and its archiving in PubMed Central, e-Depot, Potsdam and INIST. There is no remuneration of any kind provided to the Editors-in-Chief, to any members of the Editorial Board, or to peer reviewers; all of whose work is entirely voluntary. Our article-processing charge is less than charges frequently levied by traditional journals: the Journal of Neuroinflammation does not levy any additional page or color charges on top of this fee, and there are no reprint costs as publication-quality pdf files are provided, free, for distribution in lieu of reprints. Our article-processing charge will enable full, immediate, and continued Open Access for all work published in Journal of Neuroinflammation. The benefits from such Open Access will accrue to readers, through unrestricted access; to authors, through the widest possible dissemination of their work; and to science and society in general, through facilitation of information availability and scientific advancement.
Highlights
Journal of Neuroinflammation is an Open Access, online journal that is published by BioMed Central, an independent publisher committed to Open Access for peerreviewed biomedical research [1]
The Journal of Neuroinflammation will introduce article-processing charges (APCs) of around US$525 per article for manuscripts submitted on or after November 1, 2004. This charge will be waived for all authors from institutions that are BioMed Central members, and in additional cases for reasons of genuine financial hardship
The APC pays for an electronic submission process that facilitates efficient and thorough peer review, for publication costs involved in providing the article freely and universally accessible in various formats online, and for the processes required for the article's inclusion in PubMed and its archiving in PubMed Central, e-Depot, Potsdam and INIST
Summary
Journal of Neuroinflammation is an Open Access, online journal that is published by BioMed Central, an independent publisher committed to Open Access for peerreviewed biomedical research [1]. This and many other benefits led us to select Open Access publishing, and to select BioMed Central, for the Journal of Neuroinflammation. The Journal of Neuroinflammation will introduce APCs of around US$525 per article for manuscripts submitted on or after November 1, 2004 This charge will be waived for all authors from institutions that are BioMed Central members, and in additional cases for reasons of genuine financial hardship. The USA-based Public Library of Science (PLoS) is a new, non-profit organization that, like BioMed Central, is dedicated to online, Open Access publishing. This, in turn, should encourage researchers in all disciplines to understand and accept Open Access, and to accept APCs as an acceptable funding method
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.